Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Immunovant Inc (IMVT)

  • Company Report
  • Feb. 03, 2023, 15:20 UTC
  • 45

New SEC Form for Immunovant, Inc.

Comment Full text

Avantor Inc. (AVTR)

  • Company Report
  • Feb. 03, 2023, 14:10 UTC
  • 43

Avantor - Fourth Quarter 2022

Comment Full text

Lannett Co Inc (LCI)

  • Company Report
  • Feb. 03, 2023, 00:55 UTC
  • 51

New SEC Filing for Lannett Co Inc (NYSE:LCI)

Comment Full text

Rigel Pharmaceuticals Inc (RIGL)

  • Company Report
  • Feb. 03, 2023, 00:10 UTC
  • 53

Rigel Announces Publication of REZLIDHIA™(olutasidenib) Phase 2 Clinical Results in Blood Advances

Comment Full text

Cytokinetics Inc (CYTK)

  • Company Report
  • Feb. 02, 2023, 00:05 UTC
  • 49

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Comment Full text

Pfizer Inc (PFE)

  • Company Report
  • Jan. 31, 2023, 15:20 UTC
  • 51

Pfizer Inc. - Fourth Quarter 2022

Comment Full text

QuantumSi Inc (QSI)

  • Company Report
  • Jan. 31, 2023, 00:20 UTC
  • 45

New Form 8-K for Quantum-Si Incorporated

Comment Full text

Meridian Bioscience Inc. (VIVO)

  • Company Report
  • Jan. 28, 2023, 00:20 UTC
  • 50

New SEC Filing from Meridian Bioscience, Inc.

Comment Full text

Benitec Biopharma Inc. (BNTC)

  • Company Report
  • Jan. 23, 2023, 17:50 UTC
  • 47

Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program

Comment Full text

Inotiv Inc. (NOTV)

  • Company Report
  • Jan. 23, 2023, 17:00 UTC
  • 45

Inotiv - 2022 Annual Report

Comment Full text
  • Previous
  • 33
  • 34
  • 35
  • 36
  • 37
  • Next

Search

News categories

  • Technical Exchange News(9311)
  • Event(407)
  • SEC News(150692)
  • FDA Approval(8593)
  • Company Report(721)
  • Business News(103554)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin